Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. his enterprise inc
WARNING LETTER
•his enterprise inc •January 17, 2023

his enterprise inc – FDA Warning Letter, Jan 17, 2023

Record Details

The FDA issued a Warning Letter to the recipient regarding their "Adam's Secret" and "Dr. Reade Slim Sense" products, sold via www.adamssecret.com and social media. FDA laboratory analysis confirmed that "Adam’s Secret Extra Strength 3000 Platinum," "Adam’s Secret Extra Strength Blue," and "Adam's Secret Extra Strength Amazing Black" contain tadalafil. "Adam’s Secret Extra Strength Purple" and "Adam’s Secret Extra Strength 2000" contain tadalafil and sildenafil. "Dr. Reade Slim Sense" contains lorcaserin.

These undeclared pharmaceutical ingredients classify the products as unapproved new drugs under sections 505(a) and 301(d) of the FD&C Act, as they are not generally recognized as safe and effective for their intended uses. Tadalafil and sildenafil are active ingredients in FDA-approved ED drugs (Cialis, Viagra), and lorcaserin was the active ingredient in the withdrawn weight management drug Belviq. These ingredients were not marketed as dietary supplements before their drug approval or investigation, thus excluding the products from the dietary supplement definition.

Furthermore, the products are misbranded drugs under section 502 of the FD&C Act and sold in violation of section 301(a). They lack adequate directions for use (502(f)(1)) because they are prescription

Company
his enterprise inc
Inspection date
January 17, 2023
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Tina Smith (Director)
View Company Profile

ID · 6b3dd86b-f2b9-4266-8677-6af4796c67a0

Violation Codes10
21.U.S.C. 355(a)21 U.S.C. 331(d)21 U.S.C. 35221 U.S.C. 321(ff)(3)(B)(i)21 U.S.C. 321(ff)(3)(B)(ii)21 U.S.C. 321(g)(1)21 U.S.C. 321(p)21 U.S.C. 353(b)(1)(A)21 CFR 201.521 CFR 201.100(c)(2)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore his enterprise inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.